Skip to main content

Peer Review reports

From: Comparison of two biosimilarity studies of FKB327 with the adalimumab reference product: randomized phase 1 studies of single-blind, single-dose subcutaneous injection in healthy Japanese male participants

Original Submission
5 Mar 2021 Submitted Original manuscript
1 Apr 2021 Reviewed Reviewer Report - Aydın Erenmemisoglu
23 May 2021 Reviewed Reviewer Report
14 Oct 2021 Author responded Author comments - Yasumasa Arai
Resubmission - Version 2
14 Oct 2021 Submitted Manuscript version 2
22 Oct 2021 Reviewed Reviewer Report
1 Dec 2021 Author responded Author comments - Yasumasa Arai
Resubmission - Version 3
1 Dec 2021 Submitted Manuscript version 3
Publishing
17 Dec 2021 Editorially accepted
8 Jan 2022 Article published 10.1186/s40360-021-00545-3

You can find further information about peer review here.

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us